Carisma Therapeutics, Inc.

CARM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$17,909$77,605$24,194$162,636
Short-Term Investments$925$0$27,802$0
Receivables$2,864$0$0$24,493
Inventory$0$0$0$0
Other Curr. Assets$2,127$2,866$2,596$18,476
Total Curr. Assets$23,825$80,471$54,592$205,605
Property Plant & Equip (Net)$6,425$8,937$13,450$43
Goodwill$0$0$0$13,064
Intangibles$0$0$0$14,700
Long-Term Investments$0$0$0$20
Tax Assets$0$0$0$71,849
Other NC Assets$208$146$4,111$7,315
Total NC Assets$6,633$9,083$17,561$106,991
Other Assets$0$0$0$0
Total Assets$30,458$89,554$72,153$312,596
Liabilities
Payables$2,081$3,933$1,728$2,853
Short-Term Debt$1,737$1,935$4,599$0
Tax Payable$0$0$0$0
Deferred Revenue$0$1,413$2,459$0
Other Curr. Liab.$12,237$8,627$10,884$8,715
Total Curr. Liab.$16,055$15,908$19,670$11,568
LT Debt$744$1,188$35,565$0
Deferred Rev, NC$0$45,000$45,000$1,500
Deferred Tax Liab, NC$0$0$0$75,818
Other NC Liab.$41,568$926$114,588$52,000
Total NC Liab.$42,312$47,114$195,153$129,318
Other Liabilities$0$0$0$0
Cap. Leases$2,481$3,123$6,447$0
Total Liabilities$58,367$63,022$214,823$140,886
Equity
Pref Stock$0$0$0$0
Common Stock$41$40$2$199
Retained Earnings-$305,579-$245,102-$158,223-$316,257
AOCI$0$0-$41$0
Other Equity$277,629$271,594$1,197$487,768
Total Equity-$27,909$26,532-$157,065$171,710
Supplemental Information
Minority Interest$0$0$14,395$0
Total Liab. & Tot. Equity$30,458$89,554$72,153$312,596
Net Debt-$15,428-$74,482$15,970-$162,636